Low-dose Dasatinib as First-line Treatment for Chronic Myeloid Leukemia
Clinical trial NCT03216070 · UNKNOWN
Trial details
- NCT number
- NCT03216070
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2018-10-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.